Literature DB >> 16715586

Maculopathy in dengue fever.

Daniel Hsien-Wen Su, Soon-Phaik Chee.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16715586      PMCID: PMC3294711          DOI: 10.3201/eid1204.051476

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: A recent article by Chlebicki et al () described 4 patients hospitalized for dengue fever who were found to have retinal hemorrhages. These patients reported reduced visual acuity and metamorphopsia, i.e., distorted visual images attributable to intrinsic retinal disease involving the macula; macular hemorrhages and exudates were found on retinal examination. The authors concluded that the retinal hemorrhages were responsible for the patients' visual symptoms. This conclusion is misleading because retinal hemorrhages alone cause scotomas. Rather, the accumulation of subretinal fluid in the macula results in metamorphopsia and blurring of vision. In previous reports of patients in whom macular changes developed from dengue fever, some were found to have macular hemorrhages (–). In addition, clinical examination and investigation of these patients showed vasculopathologic changes in the macular region that affected the retinal and choroidal blood vessels (), although the tissues of the periphery tended to be spared. A fluorescein angiograph of the retina showed knobby hyperfluorescence of the retinal arterioles with minimal leakage, as well as some spots of leakage at the level of the retinal pigment epithelium. An indocyanine green angiograph showed diffuse hyperfluorescence of the choroid. These pathologic changes in the macula were the most likely cause of the blurring of vision in such patients, which has been the case in our experience. The article by Chlebicki et al. did not state whether these procedures had been performed on their patients to confirm or exclude retinal or choroidal vasculopathy in the macula. Therefore, these authors would have had difficulty concluding that retinal hemorrhages caused blurring of vision and metamorphopsia in patients with dengue maculopathy.
  5 in total

1.  A tourist with dengue fever and visual loss.

Authors:  Christos Haritoglou; Sarah D Dotse; Günther Rudolph; C M Stephan; S R Thurau; Volker Klauss
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

2.  Ocular manifestations of dengue fever.

Authors:  Wee-Kiak Lim; Ranjana Mathur; Adrian Koh; Ronald Yeoh; Soon-Phaik Chee
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

3.  [The ocular fundus findings in dengue fever].

Authors:  K H Wen; M M Sheu; C B Chung; H Z Wang; C W Chen
Journal:  Gaoxiong Yi Xue Ke Xue Za Zhi       Date:  1989-01

4.  [Ocular manifestation in dengue fever].

Authors:  C Haritoglou; F Scholz; A Bialasiewicz; V Klauss
Journal:  Ophthalmologe       Date:  2000-06       Impact factor: 1.059

5.  Retinal hemorrhages in 4 patients with dengue fever.

Authors:  Maciej Piotr Chlebicki; Brenda Ang; Timothy Barkham; Augustinus Laude
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

  5 in total
  3 in total

1.  Multifocal electroretinography in dengue fever-associated maculopathy.

Authors:  Timothy Y Y Lai; Shaheeda Mohamed; Wai Man Chan; Ricky Y K Lai; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

2.  Maculopathy and dengue.

Authors:  Augustinus Laude; Maciej Piotr Chlebicki; Brenda Ang; Timothy Barkham
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

3.  Dengue maculopathy: visual electrophysiology and optical coherence tomography.

Authors:  Thaís Sousa Mendes; Edmundo Frota de Almeida Sobrinho; Alexandre Antonio Marques Rosa; Laiza Medeiros dos Anjos; Genilma Matos da Costa; Givago da Silva Souza; Bruno Duarte Gomes; Cézar Akiyoshi Saito; Manoel da Silva Filho; Luiz Carlos de Lima Silveira
Journal:  Doc Ophthalmol       Date:  2009-06-18       Impact factor: 1.854

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.